Abstract
FUT-175 is a synthetic protease inhibitor and an inhibitor of the classical and alternate pathways of complement activation. In human serum, FUT-175 inhibited C3a, C4a and C5a generation induced by heat aggregated IgG, zymosan and Cobra venom factor with IC50 values in the range of 3-43 μM depending on the stimulus and the fragments. To assess in vivo anti-inflammatory activity, inflammatory reactions induced in the skin of rabbits were quantitated by using 125I-albumin extravasation, 51Cr-labelled leukocyte accumulation and 86RbCl accumulation as a measure of hyperemia. Infusion of FUT-175 at 2 mg/kg/h inhibited all three parameters by 50-80% in dermal reactions induced by killed E. coli, zymosan, immune complexes, the reversed Arthus reaction, zymosan activated plasma (ZAP), f-norleu-leu-phe (FNLP) and LTB4. In contrast, the response to endotoxin (0.1 μg) was not effected by FUT-175 treatment. The effect of FUT-175 was comparable to that of local or systemic therapy with indomethacin, but unlike indomethacin, the effect of FUT-175 was not reversed by local PGE2 administration. Furthermore, indomethacin and FUT-175 had additive anti-inflammatory effects. These results suggest that although FUT-175 is a potent inhibitor of C3a, C4a and C5a generation, it has novel and broad anti-inflammatory effects, possibly through actions in addition to complement inhibition as indicated by inhibition of FNLP-, LTB4- and ZAP-induced reactions.
Original language | English |
---|---|
Pages (from-to) | 1-9 |
Number of pages | 9 |
Journal | International Journal of Immunopharmacology |
Volume | 12 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1990 |
Bibliographical note
Funding Information:Acknowledgements -- The authors are grateful for the expert technical contributions of Paul Peters, Murray Ripley and Zbigniew Wankowicz and to Ms Nancy Steel for preparing the manuscript and figures. Also acknowledged is Dr M. Gibner and the staff of the Endocrinology Laboratory at the Victoria General Hospital Pathology Laboratory (Halifax, Nova Scotia) for measurement of serum corticosterone levels. This work was supported by grant MA 7684 from the Medical Research Council of Canada. A. lssekutz is supported in part by the grant DG-209 from the MRC of Canada.
ASJC Scopus Subject Areas
- Immunology
- Pharmacology